These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 28131778)
1. Economic evaluation of future skin cancer prevention in Australia. Shih ST; Carter R; Heward S; Sinclair C Prev Med; 2017 Jun; 99():7-12. PubMed ID: 28131778 [TBL] [Abstract][Full Text] [Related]
2. Economic evaluation of skin cancer prevention in Australia. Shih ST; Carter R; Sinclair C; Mihalopoulos C; Vos T Prev Med; 2009 Nov; 49(5):449-53. PubMed ID: 19747936 [TBL] [Abstract][Full Text] [Related]
3. Skin cancer has a large impact on our public hospitals but prevention programs continue to demonstrate strong economic credentials. Shih STF; Carter R; Heward S; Sinclair C Aust N Z J Public Health; 2017 Aug; 41(4):371-376. PubMed ID: 28664663 [TBL] [Abstract][Full Text] [Related]
4. Benefit Cost Analysis of Three Skin Cancer Public Education Mass-Media Campaigns Implemented in New South Wales, Australia. Doran CM; Ling R; Byrnes J; Crane M; Shakeshaft AP; Searles A; Perez D PLoS One; 2016; 11(1):e0147665. PubMed ID: 26824695 [TBL] [Abstract][Full Text] [Related]
5. Economic evaluation of the US Environmental Protection Agency's SunWise program: sun protection education for young children. Kyle JW; Hammitt JK; Lim HW; Geller AC; Hall-Jordan LH; Maibach EW; De Fabo EC; Wagner MC Pediatrics; 2008 May; 121(5):e1074-84. PubMed ID: 18450850 [TBL] [Abstract][Full Text] [Related]
6. The relevance of unrelated costs internal and external to the healthcare sector to the outcome of a cost-comparison analysis of secondary prevention: the case of general colorectal cancer screening in the German population. Tscheulin DK; Drevs F Eur J Health Econ; 2010 Apr; 11(2):141-50. PubMed ID: 19449159 [TBL] [Abstract][Full Text] [Related]
7. Health system costs of skin cancer and cost-effectiveness of skin cancer prevention and screening: a systematic review. Gordon LG; Rowell D Eur J Cancer Prev; 2015 Mar; 24(2):141-9. PubMed ID: 25089375 [TBL] [Abstract][Full Text] [Related]
8. Economic Evaluation of the Community Benefit of the Australian Pregnancy Register of Antiseizure Medications. Ademi Z; Marquina C; Perucca P; Hitchcock A; Graham J; Eadie MJ; Liew D; O'Brien TJ; Vajda FJ Neurology; 2023 Mar; 100(10):e1028-e1037. PubMed ID: 36460471 [TBL] [Abstract][Full Text] [Related]
9. Estimating the cost-effectiveness of needle-syringe programs in Australia. Kwon JA; Anderson J; Kerr CC; Thein HH; Zhang L; Iversen J; Dore GJ; Kaldor JM; Law MG; Maher L; Wilson DP AIDS; 2012 Nov; 26(17):2201-10. PubMed ID: 22914579 [TBL] [Abstract][Full Text] [Related]
10. The cost-effectiveness of Australia's Active After-School Communities program. Moodie ML; Carter RC; Swinburn BA; Haby MM Obesity (Silver Spring); 2010 Aug; 18(8):1585-92. PubMed ID: 19893504 [TBL] [Abstract][Full Text] [Related]
11. Why invest in a national public health program for stroke? An example using Australian data to estimate the potential benefits and cost implications. Cadilhac DA; Carter RC; Thrift AG; Dewey HM Health Policy; 2007 Oct; 83(2-3):287-94. PubMed ID: 17368861 [TBL] [Abstract][Full Text] [Related]
12. Burden of skin cancer in Belgium and cost-effectiveness of primary prevention by reducing ultraviolet exposure. Pil L; Hoorens I; Vossaert K; Kruse V; Tromme I; Speybroeck N; Brochez L; Annemans L Prev Med; 2016 Dec; 93():177-182. PubMed ID: 27713103 [TBL] [Abstract][Full Text] [Related]
13. Population genomic screening of all young adults in a health-care system: a cost-effectiveness analysis. Zhang L; Bao Y; Riaz M; Tiller J; Liew D; Zhuang X; Amor DJ; Huq A; Petelin L; Nelson M; James PA; Winship I; McNeil JJ; Lacaze P Genet Med; 2019 Sep; 21(9):1958-1968. PubMed ID: 30773532 [TBL] [Abstract][Full Text] [Related]
14. The economics of skin cancer prevention with implications for Australia and New Zealand: where are we now? Gordon LG; Shih S; Watts C; Goldsbury D; Green AC Public Health Res Pract; 2022 Mar; 32(1):. PubMed ID: 35290994 [TBL] [Abstract][Full Text] [Related]
15. Organized blood pressure control programs to prevent stroke in Australia: would they be cost-effective? Cadilhac DA; Carter R; Thrift AG; Dewey HM Stroke; 2012 May; 43(5):1370-5. PubMed ID: 22363058 [TBL] [Abstract][Full Text] [Related]
16. Melanoma screening: Informing public health policy with quantitative modelling. Gilmore S PLoS One; 2017; 12(9):e0182349. PubMed ID: 28945758 [TBL] [Abstract][Full Text] [Related]
17. Estimating the cost-effectiveness and return on investment of the Victorian Cardiac Outcomes Registry in Australia: a minimum threshold analysis. Lee P; Brennan AL; Stub D; Dinh DT; Lefkovits J; Reid CM; Zomer E; Liew D BMJ Open; 2023 Apr; 13(4):e066106. PubMed ID: 37185178 [TBL] [Abstract][Full Text] [Related]